Trial
NCT01236352
Multiple Ascending Dose of BMS-911543
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Bristol-Myers Squibb
Collaborators
—
Condition
Cancer
Intervention
BMS-911543
Why stopped
Due to portfolio/business decisions by the sponsor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-07-31